Accuracy of Lactate Meter in GSDIa

Purpose

The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.

Condition

  • Glycogen Storage Disease Type Ia

Eligibility

Eligible Ages
Between 0 Years and 60 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia (ICD 10 code: E74.01). - Connecticut Children's Emergency Department visit and/or admission to Connecticut Children's during time study is active - For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document - For adults: Ability to understand and the willingness to sign a written informed consent

Exclusion Criteria

  • Patients with Glycogen storage disease unspecified 74.00, or Ib - Patients not meeting inclusion criteria

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

Connecticut Children's Medical Center
Hartford, Connecticut 06107
Contact:
Rebecca Riba-Wolman
860-837-6700
rriba@connecticutchildrens.org

More Details

Status
Recruiting
Sponsor
Connecticut Children's Medical Center

Study Contact

Malaya Mount, MS, RD
860-837-6700
mmount@connecticutchildrens.org

Detailed Description

The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, within 20% of lab serum lactate reading 95% of the time, in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, within 20% of lab serum glucose reading 95% of the time, in a population of patients with glycogen storage disease type 1a.